GLP1R and diabetes mellitus: It is interesting to note that GLP-1 RAs have been FDA-approved since 2005 for diabetes, and it is only recently when use has become ubiquitous that concern for aspiration has also become widespread [9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58].